Day Return
YTD Return
1-Year Return
3-Year Return
5-Year Return
Note: Sector performance is calculated based on the previous closing price of all sector constituents
Industries in This Sector
Select an Industry for a Visual Breakdown
Industry | Market Weight | YTD Return | |
---|---|---|---|
All Industries | 100.00% | 11.86% | |
Drug Manufacturers - General | 34.79% | 20.50% | |
Healthcare Plans | 13.41% | 4.54% | |
Biotechnology | 11.57% | 5.47% | |
Medical Devices | 11.52% | 1.41% | |
Diagnostics & Research | 11.20% | 9.68% | |
Medical Instruments & Supplies | 7.02% | 18.54% | |
Medical Care Facilities | 3.28% | 35.45% | |
Drug Manufacturers - Specialty & Generic | 2.71% | 1.37% | |
Medical Distribution | 2.23% | 11.30% | |
Health Information Services | 2.14% | 17.95% | |
Pharmaceutical Retailers | 0.13% | -60.10% |
Note: Percentage % data on heatmap indicates Day Return
All Industries
--
<= -3
-2
-1
0
1
2
>= 3
Largest Companies in This Sector
View MoreName | Last Price | 1Y Target Est. | Market Weight | Market Cap | Day Change % | YTD Return | Avg. Analyst Rating |
---|---|---|---|---|---|---|---|
952.74 | 1,003.10 | 12.28% | Buy | ||||
584.51 | 619.83 | 7.73% | Buy | ||||
164.13 | 171.47 | 5.66% | Buy | ||||
197.55 | 196.64 | 5.00% | Buy | ||||
116.60 | 140.31 | 4.23% | Buy | ||||
606.12 | 630.67 | 3.32% | Buy | ||||
112.69 | 124.04 | 2.81% | Buy | ||||
269.48 | 284.85 | 2.79% | Buy | ||||
328.80 | 328.50 | 2.53% | Buy | ||||
486.55 | 482.39 | 2.48% | Buy |
Investing in the Healthcare Sector
Start Investing in the Healthcare Sector Through These ETFs and Mutual Funds
ETF Opportunities
View MoreName | Last Price | Net Assets | Expense Ratio | YTD Return |
---|---|---|---|---|
155.45 | 40.661B | 0.09% | ||
285.40 | 21.092B | 0.10% | ||
147.95 | 7.976B | 0.45% | ||
101.51 | 7.812B | 0.35% | ||
58.21 | 4.88B | 0.40% |
Mutual Fund Opportunities
View MoreName | Last Price | Net Assets | Expense Ratio | YTD Return |
---|---|---|---|---|
236.81 | 48.824B | 0.30% | ||
99.87 | 48.824B | 0.30% | ||
142.76 | 21.092B | 0.10% | ||
102.22 | 15.167B | 0.80% | ||
101.89 | 15.167B | 0.80% |
Healthcare Research
View MoreDiscover the Latest Analyst and Technical Research for This Sector
Analyst Report: Perrigo Company PLC
?Perrigo, founded in 1887, is a leading manufacturer of generic over-the-counter healthcare products and supplier of infant formulas for the store-brand market. Perrigo's private-label consumer products encompass a variety of cold/allergy, gastrointestinal, first aid, motion sickness, vitamin, smoking cessation, and other remedies. The company has a market cap of approximately $4 billion after divesting its RX pharmaceutical business in 2021. Headquartered in Dublin, Ireland, Perrigo has over 9,100 employees.
RatingPrice TargetAnalyst Report: Gilead Sciences, Inc.
?Gilead Sciences is a biopharmaceutical company that researches, develops, and sells therapies for treating HIV, hepatitis B, hepatitis C, and certain cancers. In October 2020, Gilead's Veklury (remdesivir) became the first approved treatment for COVID-19 in the U.S. Founded in 1987, the company is located in Foster City, California. It has operations in more than 35 countries and approximately 18,000 employees.
RatingPrice TargetMarket Update: CMS, GILD, INTU, PRGO, TJX, PTON
?Stocks are up. Fed Chairman Powell injected some rocket fuel into the market by saying, 'the time has come' to start cutting interest rates. The S&P 500 rose 1%, while the Dow gained 0.9% and the tech-heavy Nasdaq Composite was up 1.1%. The Russell 2000 added 3.3%. Both crude oil and gold were also up.
Daily – Vickers Top Buyers & Sellers for 08/23/2024
?The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.